HeyJaredHeidi Ledford
- Indexed articles, last 90 days
- 7
- Latest publication
- Sep 28, 2026
- Outlet visibility, for Nature
- Top 10K sites
- Earliest in this view
- Jul 10, 2026
Latest articles
Bigger than CRISPR? A guide to the latest genome editors (opens the original)
Read excerpt
A decade ago, Ying Zhang found herself on the cusp of a medical revolution. CRISPR crops are coming to Europe â why bolder would be better CRISPR crops are coming to Europe â why bolder would be better Zhang was one of the first scientists to be hired by CRISPR Therapeutics in Zug, Switzerland. The biotechnology firm was formed in 2013 to treat disease using CRISPRâCas9 gene editing. The technique had only recently been published, and Zhang and her colleagues were dreaming up ways to put t
Anthropicâs AI biolab finds âCRISPR-likeâ DNA in viruses. Whatâs next? (opens the original)
Read excerpt
Sure, AI can parse petabytes of data. But how well can it pipette? Regardless of the answer, artificial intelligence titan Anthropic has launched a biology âwet labâ where human scientists and AI agents will work together to design and conduct experiments. This week, the company announced one of the teamâs first finds: a peculiar pattern of DNA in the genomes of several giant viruses. Similar patterns are found in DNA encoding the CRISPR immune systems of some microbes. Scientists have dev
How fast are you ageing? Ask AI (opens the original)
Read excerpt
Understanding why people age â and how to slow that process down â is an obsession that has stretched across millennia, from mythic quests for immortality to modern scienceâs hunt for drugs that lengthen lifespan. A report1 published today in Cell unveils a bespoke artificial-intelligence system that aims to turbocharge longevity research. The system introduces large language models (LLMs) that the authors trained on ageing-biology data. It also includes a suite of 17 tasks that can serve
Cancer-fighting antibodies with a one-two punch take aim at tumours (opens the original)
Read excerpt
Cancer-fighting drugs called bispecific antibodies are having a moment. A growing number are making their way into the clinic, and researchers are developing increasingly elaborate molecules with new capabilities. Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription Receive 52 print issues and online access Prices may be subject to local taxes which are calculated during checkout doi: https://doi.org/10.1038/d41586-026-02398-4 What will be t
Bizarre CRISPR enzyme kills cancer cells by shredding their DNA (opens the original)
Read excerpt
Scientists have exploited a peculiar CRISPR enzyme so that it fights cancer by shredding the DNA in cancer cells, causing them to self-destruct. Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription Receive 52 print issues and online access Prices may be subject to local taxes which are calculated during checkout doi: https://doi.org/10.1038/d41586-026-02268-z Read the related News & Views, âDNA-shredding CRISPR enzyme takes aim at cancer c
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 10K sites
For Nature, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.